Capsule Endoscopy Systems
Ingestible wireless camera capsules imaging the small bowel and colon for diagnosis of obscure GI bleeding, Crohn disease, and small intestine conditions.
Market snapshot
These figures describe Endoscopy & GI Devices (4.8.5), the segment that Capsule Endoscopy Systems sits within — not Capsule Endoscopy Systems on its own.
Within surgical & medical instruments (NAICS 339112); the Census Bureau does not split out endoscopy/GI, so the segment is not separately sized.
Business model & economics
Revenue model
Endoscope systems plus recurring accessories and disposables
Key economics
- Recurring revenue
- High
- EBITDA margin
- 20–30%
- Capex intensity
- High
recurring accessories and single-use scopes
Characteristics
- Olympus dominates flexible endoscopes.
- Shift to single-use scopes on infection-control concerns.
- GI procedure volumes and aging drive demand.
Geographic concentration
Endoscopy and GI device manufacturing concentrates in Minnesota, Massachusetts, and California — the three med-tech hubs anchoring U.S. device design and production.
U.S. Census Bureau — 2022 County Business Patterns (establishments by state), NAICS 339112. Concentration shown by location quotient.
M&A deal context
Who’s acquiring
- Endoscopy & GI strategics
- Single-use-scope innovators' acquirers
- Diversified medtech platforms
What’s driving deals
- Single-use endoscope transition.
- GI procedure-volume and aging demand.
- Acquisition of interventional-GI innovation.
Find Capsule Endoscopy Systems acquisition targets
Search Acquisera’s index for companies classified under Capsule Endoscopy Systems (4.8.5.1) and build a targeted deal pipeline.
Search companies